Delivery Order SPE2DB22D2206-SPE2DB25FJP95
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $48,737.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in quantities of 30 units. This is a non-set-aside competitive award with an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of AYVAKIT 25 mg tablets (30-count packaging) under a firm fixed price contract valued at approximately $24.4K. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- This delivery order, awarded on August 25, 2025, authorizes AmerisourceBergen Drug Corp to supply 30 tablets of Ayvakit 25 mg under a firm fixed-price arrangement with a ceiling value of $24,368.92. The contract is performed at the company's corporate office in Conshohocken, Pennsylvania, and must be completed by September 16, 2025. The Defense Logistics Agency, under the Department of Defense, issued this non-competitive delivery order as a child contract utilizing AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $24,368.92 to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitive award, issued on July 30, 2025, with an ultimate completion date of August 20, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of AYVAKIT (avapritinib) 25 mg tablets in a quantity of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $24.4K and is structured as a firm fixed price delivery order, with an ultimate completion date of September 25, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $24,368.92 for AYVAKIT 25 mg tablets (30-count packaging) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of AYVAKIT 25 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $73,106.76, is scheduled for completion by September 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for the supply of the drug AYVAKIT 25 MG TABLET 30S. The contract has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for AYVAKIT 25 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of July 7, 2025 and is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 Firm Fixed Price Delivery Order contract is for the supply of AYVAKIT 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJP95Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $24.4K to AmerisourceBergen Drug Corp for 30 tablets of AYVAKIT 200 mg, a targeted cancer therapy medication. The contract, awarded August 25, 2025, with completion targeted for September 16, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with DLA covering diverse pharmaceutical commodities across multiple therapeutic domains. This specific delivery order reflects the company's role as a pharmaceutical prime vendor, fulfilling specialized oncology medication requirements for Defense Health Agency customers and other federal healthcare systems through the comprehensive global pharmaceutical support vehicle established by DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.4k | 8/25/25 |